Shares of Cencora Inc. COR inched 0.47% higher to $249.97 Wednesday, on what proved to be an all-around favorable trading ...

In a report released yesterday, Steve Baxter from Wells Fargo maintained a Hold rating on Cencora (COR – Research Report), with a price ...

Moving forward, Bettendorf's youth sports programs and coach-led camps can apply to use trademarked district logos, followed ...

Believe it or not, fans in the Golden State can get in on the California sports betting action – you just need to know where to go. Yes, that’s right, despite multiple bills that have failed ...

Shares of Cencora Inc. COR sank 0.77% to $231.77 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.16% to 5,832.92 and the ...

With a market cap of $46.8 billion, Cencora, Inc. (COR) focuses on pharmaceutical distribution and healthcare services. The Conshohocken, Pennsylvania-based company provides extensive solutions ...

We can see that Cencora, Inc. (NYSE:COR) does use debt in its business. But should shareholders be worried about its use of debt? Debt assists a business until the business has trouble paying it ...

Cencora COR has outperformed the market over the past 5 years by 7.66% on an annualized basis producing an average annual return of 21.48%. Currently, Cencora has a market capitalization of $46.09 ...

A large exercise of company stock options by Steven H Collis, Executive Chairman at Cencora COR was disclosed in a new SEC filing on October 23, as part of an insider exercise. What Happened ...